Concordia UK
London
About Concordia UK
Concordia UK develops, licenses, and markets generic pharmaceutical products. It also manages and markets generic and branded pharmaceutical products of other companies. Concordia UK markets products through its sales, marketing, and distribution team in Europe. It began operation as Focus Pharmaceuticals in 2002. Concordia UK's headquarters is in London in the United Kingdom. It operates as a subsidiary of Amdipharm Mercury Company as of September 30, 2014.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Website: concordiarx.com
- Phone: +44 (0) 8700 70 30 33
Social Profiles
Canonical: https://fsome.com/organization/concordia-uk-1042961 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.